Viking Therapeutics VKTX
NASDAQ VKTX
$36.75 -4.90 (-11.76%)
At close: Sep 24, 2026 · 4:00 PM EDT

Viking Therapeutics (VKTX) Amortization of Deferred Charges (2019 - 2022)

Viking Therapeutics' (VKTX) quarterly Amortization of Deferred Charges came in at $77000.0 in Q1 2022, up 6.94% year-over-year from $72000.0 in Q1 2021, and up 1.32% quarter-over-quarter from $76000.0 in Q4 2021.

Analysis

Viking Therapeutics (VKTX) Amortization of Deferred Charges (2019 - 2022) Analysis & Trends

Viking Therapeutics has disclosed Amortization of Deferred Charges across 4 years of filings, most recently posting $77000.0 for Q1 2022.

  • In Q1 2022, Amortization of Deferred Charges rose 6.94% year-over-year to $77000.0; the TTM figure through Mar 2022 stood at $301000.0 (up 7.12% YoY), while the FY2021 annual figure was $296000.0, up 6.86% from the prior year.
  • Amortization of Deferred Charges came in at $77000.0 for Q1 2022 at Viking Therapeutics, up from $76000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $77000.0 in Q1 2022 to a low of $64000.0 in Q1 2019.
  • Average Amortization of Deferred Charges over 4 years is $70000.0, with a median of $70000.0 recorded in 2020.
  • Year-over-year, Amortization of Deferred Charges grew 7.58% in 2020 and gained 5.88% in 2021.
  • Over 4 years, Amortization of Deferred Charges stood at $66000.0 in 2019, then grew by 7.58% to $71000.0 in 2020, then gained by 7.04% to $76000.0 in 2021, then increased by 1.32% to $77000.0 in 2022.
  • Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $77000.0 in Q1 2022, $76000.0 in Q4 2021, and $75000.0 in Q3 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn
10 Viking Therapeutics 4.86 Bn 4.86 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 77,000.00
Dec 31, 2021 76,000.00
Sep 30, 2021 75,000.00
Jun 30, 2021 73,000.00
Mar 31, 2021 72,000.00
Dec 31, 2020 71,000.00
Sep 30, 2020 70,000.00
Jun 30, 2020 68,000.00
Mar 31, 2020 68,000.00
Dec 31, 2019 66,000.00
Sep 30, 2019 66,000.00
Jun 30, 2019 64,000.00
Mar 31, 2019 64,000.00
API Access

Viking Therapeutics Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=VKTX&period=max&api_key=YOUR_API_KEY